L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard Stephen Sunderland Read more
Related Practice MedTech Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption 07102020100744
Executive Insights MedTech Medtech CDMOs in Southeast Asia: Landscape Overview and Investment Opportunities June 17, 2025
Executive Insights Digital Your AI Transformation Needs a Different Leadership Approach March 7, 2025
Case Study Private Equity Future Ready: Comprehensive Operational Due Diligence on a Medtech and Life Sciences… February 24, 2025 A private equity firm approached L.E.K. Consulting to conduct operational due diligence on a promising precision medtech and life sciences engineering…
Executive Insights Telehealth and Digital Transformation Healing Bytes: A Prescription for Commercializing Healthcare Data in Asia and the Middle… October 23, 2024
